Carcinoembryonic Antigen (CEA)

Catalogue Number: 151-10
Product Name Carcinoembryonic Antigen
Source Human Metastatic Liver Carcinoma
Catalogue Number 151-10
Purity > 95% (SDS-PAGE)
Form Liquid
Protein Report mg/mL (A280)
Formulation Solution in 20 mM tris, 100 mM sodium chloride, pH 7.4 with 0.05% sodium azide.
Related Products 151-09 - Carcinoembryonic Antigen from human liver - Lyophilized
151-12 - anti-Human Carcinoembryonic Antigen polyclonal antibody
151-53 - Cancer Antigen 15-3 from human ascites fluid
Storage -20°C
Recertification 4 years
Infectious Disease Testing Negative or non-reactive at the donor level for anti-HIV 1 and 2, anti-HCV and HBsAg by FDA approved methods.
Synonyms CEA, Carcinoembryonic antigen-related cell adhesion molecule 5, Meconium antigen 100, CD_antigen=CD66e
Gene CEACAM5, CD66e, CEA
Molecular Weight ~180,000
Gene ID 1048
Accession No P06731

Lee Biosolutions is a producer and supplier of high purity human Carcinoembryonic Antigen (CEA), a marker for bowel cancer, colorectal carcinoma, lung cancer research and diagnostic manufacturing.

Custom preparations, technical support, bulk quantities and aliquoting available, email for more details.

Serum tumor marker human Carcinoembryonic antigen (CEA) is a glycoprotein involved in cell adhesion. It is normally produced during fetal development, but the production stops before birth. Therefore, serum tumor marker human CEA is not usually present in the blood of healthy adults, although levels are raised in heavy smokers.

Associated Cancer Types: Gastrointestinal, Cervix, Lung, Ovarian, Breast and Urinary Tract Cancer

Add to Cart
151-10-0.1 $ 332.00 100 ug
151-10-1 $ 1,589.00 1 mg